Delivery Order SPE2DB22D1106-SPE2DB25FFAJ1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,228.56 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose, an antibiotic pharmaceutical product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger federal contracting portfolio with the agency. This delivery order derives...
- The Defense Logistics Agency awarded a $1,023.75 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed in Conshohocken, Pennsylvania. The order represents a delivery against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $1,638.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with dextroses, with a completion date of September 8, 2025. The award was made on September 5, 2025, and is non-set-aside, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Cefazolin 2G/50ML with dextrose solutions. This firm fixed-price delivery order, valued at $4,095.20, represents a competitively awarded contract with an ultimate completion date of June 2, 2025. The award was issued to the Corporate Office division of AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,373.84 for Cefazolin 1 GM vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger...
- The Defense Logistics Agency awarded a $1,630.47 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextroses, an antibiotic pharmaceutical product. The contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,228.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML-Dextrose, a pharmaceutical product used in military and federal healthcare systems. The award was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,457.12 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Cefazolin 2G/50ML with dextrose solutions. This competitively awarded contract utilizes firm fixed-price terms with an ultimate completion date of September 9, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,638.08 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cefazolin 2G/50ML-Dextroses, an antibiotic medication in intravenous form. The contract employs firm fixed price terms with an ultimate completion date of September 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAJ1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,023.75 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML in dextrose solution. The contract employs firm fixed price terms and is scheduled for ultimate completion on July 30, 2025, just one day after the award date of July 29, 2025. This delivery order was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies critical medical commodities to support federal military healthcare programs, including specialty medications, generic drugs, and related medical supplies. The IDC vehicle enables the company to fulfill pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis, with DLA planning to establish next-generation pharmaceutical prime vendor contracts across multiple regions with multiple contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/29/25 |